Full text is available at the source.
Abstract
Obesity is associated with an increased risk of several cancers, including colorectal cancer, pancreatic cancer, and hepatocellular carcinoma.
- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may lower the risk of certain cancers related to obesity.
- Most existing studies have focused on patients with diabetes rather than those using GLP-1 RAs for weight loss.
- The effects of GLP-1 RAs on nondiabetic patients remain unclear.
Simplified